Ellie T.Y. Mok 37th Lorne Cancer Conference 2025

Abstracts this author is presenting:

• A clinically approved copper chelator in combination with standard-of-care chemotherapy reduces tumour desmoplasia and metastasis in PDAC — Poster Session II